[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595546":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":54,"collaborators":12,"id":57,"slug":12,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":12,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":12,"enrollmentInfo":65,"targetDuration":12,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":12,"overallStatus":40,"whyStopped":12,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Shahid Beheshti University of Medical Sciences","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of care","NO_INTERVENTION","Advograf plus Cellcept plus Prednisolone",null,{"label":14,"type":6,"description":15,"interventionNames":16},"Intervention","Advograf plus Rapamiune plus Prednisolone",[17],"Drug: Rapamune Pill",[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Rapamune Pill","Rapamiune Tablet 1mg daily plus Advograf plus prednisolone",[14],[25],"Sirolimus",[27],{"name":28,"affiliation":29,"role":30},"Dalili","SBMU","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":12,"email":36},"PI","CONTACT","00989122404331","dr.nooshindalili@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":12,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Nooshin Dalili","RECRUITING","Tehran","1666663421","Iran",{"type":45,"coordinates":46},"Point",[47,48],51.42151,35.69439,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":35,"phoneExt":12,"email":53},"Nooshin Dalili, Dr","nooshindalili4@gmail.com",{"type":30,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"nooshin dalili","assistant professor","100595546",false,"NCT07033858","Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation","Investigating the Effect of Low-dose Extended-release Tacrolimus and Sirolimus on the Short-term Outcomes of Allograft Kidney Transplantation","Inclusion Criteria:\n\n* All Kidney transplant recipients\n\nExclusion Criteria:\n\n* Kidney-Pancreas transplant BMI\\>30 cPRA\\>0%","ALL","18 Years",{"count":66,"type":67},50,"ESTIMATED","INTERVENTIONAL",[70],"NA","Cornerstone immunosuppressive therapy currently relies on immediate-release tacrolimus, a calcineurin inhibitor (CNI) that is potentially nephrotoxic and is more diabetogenic than cyclosporine A. A new formulation of tacrolimus has been launched: an extended-release formulation (Advagraf®\u002FAstagraf XL®, Astellas company).",[73],"Kidney Transplant; Complications","2025-06-14",{"date":76,"type":77},"2025-06-24","ACTUAL",{"date":79,"type":77},"2025-03-01",{"date":81,"type":67},"2026-07-01",{"name":5,"class":6},1]